Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah, Chandani Sen, Arunima Purkayastha, Donald B. Kohn, Mark S. Parcells, Sebastian Beck, Heeyoung Kim, Malina A. Bakowski, Melanie G. Kirkpatrick, Laura Riva, Karen C. Wolff, Brandon Han, Constance Yuen, David Ulmert, Prabhat K. Purbey, Philip Scumpia, Nathan Beutler, Thomas F. Rogers, Arnab K. Chatterjee, Gülsah Gabriel, Ralf Bartenschlager, Brigitte Gomperts, Clive N. Svendsen, Ulrich A.K. Betz, Robert D. Damoiseaux, Vaithilingaraja Arumugaswami

Open source

DOI: 10.1016/j.celrep.2021.108940
Published: 2021-04
Container: Cell Reports
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.celrep.2021.108940,
  title = {Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication},
  author = {Gustavo Garcia and Arun Sharma and Arunachalam Ramaiah and Chandani Sen and Arunima Purkayastha and Donald B. Kohn and Mark S. Parcells and Sebastian Beck and Heeyoung Kim and Malina A. Bakowski and Melanie G. Kirkpatrick and Laura Riva and Karen C. Wolff and Brandon Han and Constance Yuen and David Ulmert and Prabhat K. Purbey and Philip Scumpia and Nathan Beutler and Thomas F. Rogers and Arnab K. Chatterjee and Gülsah Gabriel and Ralf Bartenschlager and Brigitte Gomperts and Clive N. Svendsen and Ulrich A.K. Betz and Robert D. Damoiseaux and Vaithilingaraja Arumugaswami},
  year = {2021},
  journal = {Cell Reports},
  doi = {10.1016/j.celrep.2021.108940},
  url = {https://doi.org/10.1016/j.celrep.2021.108940}
}

RIS

TY  - JOUR
TI  - Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication
AU  - Gustavo Garcia
AU  - Arun Sharma
AU  - Arunachalam Ramaiah
AU  - Chandani Sen
AU  - Arunima Purkayastha
AU  - Donald B. Kohn
AU  - Mark S. Parcells
AU  - Sebastian Beck
AU  - Heeyoung Kim
AU  - Malina A. Bakowski
AU  - Melanie G. Kirkpatrick
AU  - Laura Riva
AU  - Karen C. Wolff
AU  - Brandon Han
AU  - Constance Yuen
AU  - David Ulmert
AU  - Prabhat K. Purbey
AU  - Philip Scumpia
AU  - Nathan Beutler
AU  - Thomas F. Rogers
AU  - Arnab K. Chatterjee
AU  - Gülsah Gabriel
AU  - Ralf Bartenschlager
AU  - Brigitte Gomperts
AU  - Clive N. Svendsen
AU  - Ulrich A.K. Betz
AU  - Robert D. Damoiseaux
AU  - Vaithilingaraja Arumugaswami
PY  - 2021
JO  - Cell Reports
DO  - 10.1016/j.celrep.2021.108940
UR  - https://doi.org/10.1016/j.celrep.2021.108940
ER  -

APA

Garcia, G., Sharma, A., Ramaiah, A., Sen, C., Purkayastha, A., Kohn, D. B., Parcells, M. S., Beck, S., Kim, H., Bakowski, M. A., Kirkpatrick, M. G., Riva, L., Wolff, K. C., Han, B., Yuen, C., Ulmert, D., Purbey, P. K., Scumpia, P., Beutler, N., Rogers, T. F., Chatterjee, A. K., Gabriel, G., Bartenschlager, R., Gomperts, B., Svendsen, C. N., Betz, U. A., Damoiseaux, R. D., & Arumugaswami, V. (2021). Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication. Cell Reports. https://doi.org/10.1016/j.celrep.2021.108940

Source records

crossref · retrieved 2026-09-25T15:40:46.796Z